Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD Bank of England Statistics AD Investing.com Markets AD LSEG Data AD CME Group Education
City & Markets

MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57

Trade Hub UK regulation desk (2026-10-03): The average one-year price target for MIRA Pharmaceuticals (NASDAQCM:MIRA) (DB:K6S) has been revised to $3.57 / share. This is an increase of 16.67% from the… Primary source: original at Nasdaq (nasdaq.com).

By Nasdaq

MIRA Pharmaceuticals Consensus Price Target Increased by 16.67% to $3.57

The average one-year price target for MIRA Pharmaceuticals (NASDAQCM:MIRA) (DB:K6S) has been revised to $3.57 / share. This is an increase of 16.67% from the prior estimate of $3.06 dated January 11, 2026. These figures represent aggregate analyst targets collected by Fintel, rat

Read at source

Read also
  1. Rogers Consensus Price Target Increased by 11.54% to $197.20
  2. TPG Mortgage Investment Trust, Inc. - Corporate Bond Price Target Increased by 14.75% to $40.50
  3. IN8bio Consensus Price Target Raised 12% to $7.14
  4. TPG Mortgage Investment Trust, Inc. - Corporate Bond Price Target Increased by 13.94% to $40.59
  5. Form 144 ANALOG DEVICES INC For: 2 October

Source: Nasdaq